VR Adviser as of June 30, 2020
Portfolio Holdings for VR Adviser
VR Adviser holds 16 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Constellation Pharmceticls I | 28.9 | $121M | 4.0M | 30.05 | |
| Trillium Therapeutics Com New | 13.2 | $55M | 6.8M | 8.09 | |
| Altimmune Com New (ALT) | 11.5 | $48M | 4.5M | 10.71 | |
| Relmada Therapeutics (RLMD) | 7.2 | $30M | 668k | 44.75 | |
| Surface Oncology | 6.1 | $25M | 3.9M | 6.56 | |
| Keros Therapeutics (KROS) | 6.0 | $25M | 672k | 37.51 | |
| Vaxart Com New (VXRT) | 5.9 | $25M | 2.8M | 8.85 | |
| Myovant Sciences | 4.2 | $17M | 845k | 20.62 | |
| Marinus Pharmaceuticals | 3.5 | $15M | 5.7M | 2.54 | |
| Inari Medical Ord (NARI) | 2.7 | $11M | 235k | 48.44 | |
| Kura Oncology (KURA) | 2.2 | $9.4M | 575k | 16.30 | |
| Syndax Pharmaceuticals (SNDX) | 2.2 | $9.3M | 626k | 14.82 | |
| Avadel Pharmaceuticals Spons Adr | 2.0 | $8.5M | 1.1M | 8.08 | |
| Adaptimmune Therapeutics Spons Adr (ADAP) | 1.9 | $7.8M | 782k | 10.01 | |
| 89bio (ETNB) | 1.4 | $5.8M | 291k | 19.93 | |
| Sierra Oncology Com New | 1.1 | $4.6M | 379k | 12.10 |
